NCT00454103View on ClinicalTrials.gov

Evaluation of 123I-Iodometomidate for Adrenal Scintigraphy

PHASE1/PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

March 31, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

February 28, 2009

Conditions
Adrenal TumorAdrenocortical Carcinoma
Interventions
DRUG

123I-Iodometomidate

Trial Locations (1)

D-97080

Würzburg

All Listed Sponsors
lead

University of Wuerzburg

OTHER

NCT00454103 - Evaluation of 123I-Iodometomidate for Adrenal Scintigraphy | Biotech Hunter | Biotech Hunter